Bessemer Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$182M Buy
370,265
+4,969
+1% +$2.7M 0.29% 83
2025
Q4
$212M Sell
365,296
-175,054
-32% -$99M 0.33% 72
2025
Q3
$262M Buy
540,350
+1,919
+0.4% +$893K 0.4% 52
2025
Q2
$218M Sell
538,431
-87,183
-14% -$36.5M 0.35% 69
2025
Q1
$311M Sell
625,614
-8,425
-1% -$4.56M 0.56% 43
2024
Q4
$330M Sell
634,039
-15,801
-2% -$8.69M 0.54% 42
2024
Q3
$402M Sell
649,840
-294,666
-31% -$174M 0.66% 32
2024
Q2
$522M Buy
944,506
+109,187
+13% +$62.6M 0.92% 19
2024
Q1
$485M Sell
835,319
-15,584
-2% -$8.74M 0.88% 21
2023
Q4
$452M Buy
850,903
+6,612
+0.8% +$3.2M 0.88% 22
2023
Q3
$427M Sell
844,291
-14,410
-2% -$7.68M 0.94% 20
2023
Q2
$448M Buy
858,701
+83,671
+11% +$45.2M 0.95% 19
2023
Q1
$447M Sell
775,030
-48,908
-6% -$27.6M 1.06% 15
2022
Q4
$454M Sell
823,938
-135,152
-14% -$71.6M 1.11% 12
2022
Q3
$486M Sell
959,090
-3,352
-0.3% -$1.88M 1.27% 11
2022
Q2
$523M Buy
962,442
+955
+0.1% +$526K 1.3% 12
2022
Q1
$568M Buy
961,487
+14,847
+2% +$8.53M 1.19% 13
2021
Q4
$632M Buy
946,640
+79,802
+9% +$49.8M 1.27% 11
2021
Q3
$495M Buy
866,838
+7,580
+0.9% +$4.16M 1.06% 16
2021
Q2
$433M Sell
859,258
-196,218
-19% -$92.6M 0.94% 22
2021
Q1
$482M Sell
1,055,476
-113,006
-10% -$53.9M 1.15% 16
2020
Q4
$544M Buy
1,168,482
+97,798
+9% +$45.9M 1.43% 10
2020
Q3
$473M Buy
1,070,684
+44,300
+4% +$18.3M 1.4% 12
2020
Q2
$372M Buy
1,026,384
+16,460
+2% +$5.52M 1.17% 16
2020
Q1
$286M Buy
1,009,924
+192,698
+24% +$60.8M 1.15% 17
2019
Q4
$265M Sell
817,226
-4,769
-0.6% -$1.45M 0.86% 26
2019
Q3
$239M Sell
821,995
-113,919
-12% -$32.6M 0.85% 26
2019
Q2
$275M Sell
935,914
-8,512
-0.9% -$2.34M 0.93% 25
2019
Q1
$259M Sell
944,426
-360,811
-28% -$89.8M 0.99% 23
2018
Q4
$292M Buy
1,305,237
+2,356
+0.2% +$553K 1.27% 13
2018
Q3
$318M Sell
1,302,881
-19,280
-1% -$4.44M 1.18% 17
2018
Q2
$274M Buy
1,322,161
+1,792
+0.1% +$380K 1.06% 22
2018
Q1
$273M Buy
1,320,369
+5,268
+0.4% +$1.11M 1.06% 19
2017
Q4
$250M Sell
1,315,101
-8,584
-0.6% -$1.64M 0.97% 27
2017
Q3
$250M Buy
1,323,685
+2,635
+0.2% +$477K 1% 17
2017
Q2
$230M Sell
1,321,050
-14,448
-1% -$2.43M 0.93% 30
2017
Q1
$205M Buy
1,335,498
+24,264
+2% +$3.71M 0.86% 35
2016
Q4
$185M Buy
1,311,234
+9,236
+0.7% +$1.36M 0.85% 25
2016
Q3
$207M Buy
1,301,998
+44,744
+4% +$6.89M 1.04% 16
2016
Q2
$186M Buy
1,257,254
+40,141
+3% +$5.92M 1.02% 18
2016
Q1
$172M Sell
1,217,113
-356,465
-23% -$47.8M 0.97% 21
2015
Q4
$223M Sell
1,573,578
-7,478
-0.5% -$997K 1.24% 11
2015
Q3
$193M Buy
1,581,056
+27,379
+2% +$3.57M 1.11% 15
2015
Q2
$202M Buy
1,553,677
+2,652
+0.2% +$346K 1.05% 18
2015
Q1
$208M Buy
1,551,025
+684,722
+79% +$88.3M 1.06% 22
2014
Q4
$109M Sell
866,303
-10,659
-1% -$1.3M 0.58% 70
2014
Q3
$107M Buy
876,962
+3,180
+0.4% +$387K 0.61% 57
2014
Q2
$103M Sell
873,782
-1,002
-0.1% -$118K 0.63% 57
2014
Q1
$105M Sell
874,784
-491,754
-36% -$58.5M 0.71% 51
2013
Q4
$152M Buy
1,366,538
+26,635
+2% +$2.65M 1.09% 21
2013
Q3
$123M Buy
1,339,903
+39,464
+3% +$3.57M 1% 26
2013
Q2
$110M Buy
+1,300,439
New +$108M 0.99% 31

Other funds holding TMO

Bessemer Group's TMO Position: Q1 2026 in Review

Bessemer Group increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q1 2026, buying an estimated $2.7M and bringing the position to 370,265 shares worth $182M. The position accounts for 0.29% of the portfolio, ranked #83.

Bessemer Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $632M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Bessemer Group held 370,265 shares of Thermo Fisher Scientific worth $182M as of Q1 2026.
  • Bessemer Group bought 4,969 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.7M.
  • Thermo Fisher Scientific made up 0.29% of Bessemer Group's portfolio in Q1 2026, its #83 holding.
  • Bessemer Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Bessemer Group's Thermo Fisher Scientific position peaked at $632M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.